Pfizer Ousts Moderna as Day Traders’ Favorite Vaccine Maker
This article is for subscribers only.
Move over Moderna Inc., Pfizer Inc. is the new day traders’ favorite Covid-19 vaccine stock.
Pfizer climbed about 9% in the the four trading days through Tuesday, with retail traders snapping up about $63 million of the shares on Tuesday alone, according to data from Vanda Research. The day-trading crowd sold off more positions than they bought in Moderna and BioNTech.